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Abstract 
Objective: To describe successes and barriers with the development and implementation of a community pharmacy medication 
therapy management-based transition of care program in the managed Medicaid population. 
Setting: A single supermarket chain pharmacy  
Practice description: Community pharmacists provide dispensing and non-dispensing pharmacy services including medication 
therapy management, biometric wellness screenings, and immunizations.   
Practice innovation: Developed and implemented a community pharmacy medication therapy management-based transition of care 
program for patients with managed Medicaid  
Main outcome measures: Feasibility of developing and implementing a transition of care service in a community pharmacy 
Results: During the first six months, a total of 17 patients were seen as part of the program.  Study pharmacists identified successes 
and potential strategies for overcoming barriers. 
Conclusion: Developing and implementing a community pharmacy transition of care program for patients with managed Medicaid 
was logistically feasible.  
 
 
Introduction 
Increasing national attention has been placed on hospital 
readmission rates as a result of the Affordable Care Act.
1
  
Approximately two-thirds of hospitals will face a total of $280 
million in penalties in 2013 for excessive readmissions.
2
  
Disparities based on insurance status have been reported.  
Adults 18-64 years of age with Medicaid have higher hospital 
readmission rates compared to patients with private  
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insurance or who are uninsured.
3
  It is projected that in 2016 
and beyond, an additional 15-17 million individuals will be 
insured through Medicaid.
4,5
  The number of patients 
impacted by disparities related to hospital readmission rates 
may increase as a result of the expansion of Medicaid in some 
states.  
 
Pharmacists have demonstrated improved patient health 
outcomes through the provision of medication therapy 
management (MTM) services.
6-8
  More recently, clinical 
studies and policy statements have described the potential 
role of pharmacists in assisting patients as they transition 
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from the hospital to home.
9-17
 Limited information exists 
regarding successes and barriers that pharmacists face when 
providing MTM-based transition of care (TOC) services in the 
community pharmacy.   
 
Given the impact of excessive readmissions, as well the 
accessibility of community pharmacists, value may exist in 
developing collaborative approaches to combat readmission 
issues.  The primary aim of this pilot study was to assess the 
feasibility of developing and implementing a community 
pharmacy-based TOC service in collaboration with an insurer.  
The community pharmacy partnered with CareSource, a 
Medicaid managed care plan.  Effective July 2012, all 900,000 
members in Ohio insured through this company became 
eligible for reimbursable MTM services.
18,19
  The purpose of 
this article is to provide practical information gained from the 
six-month pilot project. 
 
Setting and Practice Description  
The TOC service was implemented in one supermarket chain 
pharmacy located in a rural, underserved community in Ohio.  
At the time of the study, 17% of the 66,000 individuals in the 
county lived below the federal poverty level.
20,21
  
Approximately 2,100 prescriptions were dispensed per week, 
including those filled through the 340B Drug Pricing Program 
for patients receiving care at a local Federally Qualified 
Health Center (FQHC).  All pharmacists at the community 
pharmacy provided non-dispensing services, resulting in 
approximately 350 MTM claims primarily for patients insured 
through Medicare or Medicaid, 250 employee biometric 
wellness screenings, and 1050 vaccines administered.  
Patients who received MTM services were primarily recruited 
through conversations with pharmacy staff when obtaining 
prescriptions at the pharmacy or through telephone calls 
initiated by pharmacists.  A private office was available for 
non-dispensing services.  Staff included two full-time and two 
part-time pharmacists, five full-time and four part-time 
technicians, and one community pharmacy resident.   
 
Practice Innovation 
Pharmacists identified a lack of medication-related services 
for patients transitioning from an inpatient to outpatient 
setting.  In collaboration with the managed Medicaid insurer 
and university-based researchers, a proposal was developed 
for a community pharmacy TOC that built upon MTM core 
elements.
22
 The primary differences between this service and 
the existing MTM program at the community pharmacy were 
additional interview questions related to the hospitalization 
and follow up plans with other clinicians, reconciliation of 
discharge documents when available, and data collection 
associated with the study.  The pilot project was initiated in 
November 2012 after IRB approval from Ohio Northern 
University.  The resident and one pharmacist provided the 
TOC service.   
 
The insurer used health-system claims to identify patients 
recently discharged from a health care facility.  Eligible 
patients included those who were 18 years of age and older, 
resided within the county the supermarket chain pharmacy 
was located, were insured by the managed Medicaid plan, 
and were hospitalized within the past 14 days.  Potential 
participants were eligible for the study regardless of where 
they typically obtained prescription medications.  Study 
pharmacists encouraged patients to continue to use their 
current pharmacy for dispensing services. Contact 
information and prescription claims records for those 
individuals meeting the inclusion criteria were sent to 
OutcomesMTM, an internet-based MTM platform, and 
loaded into a database unique to this project.  The 
pharmacist in charge of the study was notified via e-mail 
when patients were uploaded into the platform.   
 
Study pharmacists called eligible patients to invite them to 
participate in a face-to-face comprehensive medication 
review (CMR) with telephone follow-up.  The study 
investigators deemed it prudent to conduct a CMR, as 
opposed to a targeted review of new or changed therapies, as 
it has been reported that 70% of 30-day hospital readmission 
rates are not a result of an exacerbation of the same disease 
state.
23 
 Pharmacists attempted to contact patients via phone 
until they scheduled an appointment, refused the service, or 
were documented as being unable to be reached on at least 
three different dates and times.   
 
Face-to-face patient appointments primarily occurred at the 
supermarket chain pharmacy.  A second supermarket chain 
pharmacy site within the county was also available.  When a 
patient preferred to be seen at the second location, a study 
pharmacist would travel to that pharmacy to meet with the 
patient.  Patients who received care at a local FQHC had the 
choice to see the community pharmacist at the supermarket 
chain pharmacy or FQHC.   
 
Patients were asked to bring all prescription and non-
prescription therapies as well as discharge paperwork with 
them to the visit.  During the session, each medication was 
reviewed for indication, safety, effectiveness, and adherence.  
When available, medications and the discharge medication 
list were reconciled with the patient.  Recommendations that 
reinforced appropriate medication use and lifestyle 
modification were made to the patient during the visit.  
Recommendations that required prescriber action, such as 
starting, stopping, or changing a prescription therapy were 
sent to the prescriber via phone or fax within 24 hours of the 
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appointment.  Recommendations for patients receiving 
primary care at the FQHC were communicated via the 
prescriber’s electronic health record.   
 
Patients were mailed a copy of their personal medication 
record (PMR) and medication-related action plan (MAP) that 
described the recommendations made by the pharmacist 
during the encounter.  In situations where the prescriber was 
sent a recommendation and there was no evidence that the 
recommendation was acted upon by the time the PMR was 
mailed to the patient, the pharmacist was able to include that 
recommendation on the MAP.  Patients were encouraged to 
take their PMR and MAP to their upcoming appointment and 
discuss any recommendations made by the pharmacist 
directly with their clinician. 
 
Telephone follow-up with the patient occurred 10-14 days 
after the encounter.  Based on individual patient need, 
telephone follow-up was also available before and after that 
time period.  Example topics included medication changes, 
medication access, adherence, and adverse effects.  
Pharmacists also encouraged persistence in self-management 
behaviors.   
 
The payment rate for this service mirrored the contracted 
rate for other MTM services provided by the community 
pharmacists for patients insured through the Medicaid 
managed care plan.  This included a payment for the face-to-
face CMR, as well as additional payments for each medication 
issue that was identified, resolved, and billed through the 
MTM platform.   
 
The primary aim of this pilot study was to assess the 
feasibility of developing and implementing a TOC service in a 
community pharmacy. In addition, study pharmacists 
assessed the number of pharmacologic and non-
pharmacologic recommendations made. Other outcomes 
included 30 and 90 day hospital readmission rates stratified 
by age, gender, and diagnosis, as well as the rate of physician 
and emergency department visits within 30 days of hospital 
discharge.  
 
Preliminary Outcomes  
During the initial six-month pilot project, 84 patients were 
referred to the study, of which 30 individuals (35.7%) could 
not be reached via telephone.  Study pharmacists identified 
11 individuals (13.1%) as not being appropriate candidates for 
the service, including patients or caregivers reporting end-of-
life care, home health care handling medications, one or 
fewer medications, or a scheduled MTM session at a different 
community pharmacy.   
 
A total of 43 potential participants were reached and 
identified as being appropriate candidates for the service.  
Sixteen individuals (19%) refused the service, commonly 
reporting no medication changes during the recent 
hospitalization or indicating that they spoke with a different 
health care professional regarding their medications.  
Twenty-seven individuals scheduled an appointment with a 
study pharmacist, of which 17 (62.9%) presented for the 
appointment.  The percent of patients who presented for 
their scheduled appointment was only slightly lower than 
reported elsewhere in literature for patients with managed 
Medicaid.
24
   
 
Demographic information for enrolled participants is included 
in table 1.  Reasons for hospital admission included medical 
conditions (n=11), mental health conditions (n=4), or 
pregnancy-related issues (n=2).  The face-to-face encounters 
lasted an average of 44 minutes (range 20-60 minutes).  The 
average amount of time between hospital discharge and 
MTM session was eight days (range 0-15 days).  In the one 
unique case where the number of days was reported as zero, 
the patient went home and then was briefly re-hospitalized.  
The pharmacy received the referral from the initial discharge 
on the same day that the patient went home for the second 
time.  When contacted, the patient agreed to come to the 
pharmacy later that day.  
 
Study pharmacists identified 50 medication-related and 36 
behavior modification recommendations (table 2).  Behavior 
modification recommendations were provided when the 
behavior change would likely support positive therapeutic 
outcomes for patients.  It is recommended that patients 
practice self-management behaviors after hospital discharge 
as a part of a comprehensive strategy to decrease 
unnecessary rehospitalizations.
25
  
 
Because patients obtained medications at outside pharmacies 
and there was no built in process requiring clinician follow up 
regarding recommendations, acceptance rates could not be 
accurately calculated.  In general, the number of medication-
related and behavior modification recommendations 
increased as the number of medications increased (table 3).  
Due to limited sample size to date, results for the other listed 
outcomes will not be addressed at this time, as they were not 
the primary outcome. 
 
Successes and Strategies to Overcome Barriers 
Throughout the implementation phase, a number of 
successes and barriers were identified.  Potential strategies to 
successfully overcome barriers are presented in the 
remaining portion of this manuscript.  It is anticipated that 
community pharmacists with an interest in TOC services may 
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be able to utilize this information when developing services 
within their communities.   
 
Goal:  Identify patients who have recently been discharged 
from a health facility 
Barrier:  Many community pharmacies lack a process to 
identify recently discharged patients. 
 
Strategy:  Partnering with a third-party insurer allowed the 
community pharmacy to obtain contact information for 
discharged patients.  The third-party insurer utilized claims 
data to identify eligible patients.  One benefit of working with 
an insurer was that patients discharged from multiple health 
facilities were referred to the program.  In some 
communities, this may represent a significant number of 
patients, especially if patients seek specialty care at academic 
medical centers outside the local community.  Community 
pharmacies may also consider partnering directly with a 
hospital or clinic.  Shared medical information may help to 
identify patients at high risk for hospital readmission.   
 
Goal:  Invite eligible patients to enroll in the MTM-based 
TOC program 
Barrier:  Phone contact was determined to be most 
appropriate as contacting patients quickly was a priority.  Of 
the 84 potential participants who were referred, 30 (35.7%) 
were unable to be reached via phone as a result of 
disconnected or incorrect phone numbers. 
 
Strategy:  When phone contact was unsuccessful, 
prescription claims data from the MTM platform was utilized 
to identify previous prescribers.  Updated phone numbers 
were requested from these offices.  Developing an additional 
partnership with local hospitals may increase access to 
updated contact information or may allow the community 
pharmacist to initiate contact prior to discharge.   
 
An alternative strategy may involve mailing a joint letter from 
the insurer and community pharmacy.  Written literature 
should be carefully prepared as 60% of patients with 
Medicaid have basic or below basic health literacy.
26  
In this 
case, state regulation limited the feasibility of mailing a letter 
for the pilot project.   
 
Goal:  Identify patients who are appropriate candidates for 
the service 
Barrier:  Prospective identification of patients who might 
benefit from the service was challenging, particularly because 
the reason for hospitalization and the current number of 
medications were not available prior to speaking with the 
patient. 
 
Strategy:  Pharmacists reached out via telephone to all 
recently discharged adults regardless of the number of 
medications recorded in the MTM platform.  Discrepancies 
between claims data and actual number of medications were 
frequent.  Some causes of discrepancies included the use of 
medication obtained prior to eligibility with insurer, sample 
medications, non-prescription therapies (including over-the-
counter, dietary and herbal supplements), and the lack of 
immediate claims data in the MTM platform.  
 
Contacting all patients provided insight into needs related to 
medication and health conditions.  Obtaining up-to-date 
health information, such as reason for hospitalization and the 
discharge medication list prior to contacting patients may 
allow high-risk patients to be more carefully targeted for TOC 
services.  Further partnership with a hospital may allow 
inpatient clinicians to identify high-risk patients and share 
appropriate information with the community pharmacist to 
provide additional support and care to the patient.   
 
Goal:  Decrease barriers that might impede participation  
Barrier:  Patients insured through Medicaid may have limited 
access to reliable transportation, which may increase missed 
appointment rates.  Patients may not feel well enough to visit 
the community pharmacy within several days of discharge. 
 
Strategy:  Identifying strategies to overcome structural 
barriers in the local community may increase patient 
participation in services.  During part of this program, a 
driving service was made available by the managed Medicaid 
plan for patients without access to personal transportation; 
however, no patients utilized this service.  As pharmacists 
saw patients at multiple locations, including those accessible 
via a bus route, the need for additional transportation 
services may have decreased.   
 
Some patients reported not feeling well enough to visit the 
pharmacy within several days of discharge.  While the goal 
was to see patients within three days of notification of 
discharge, patients frequently selected later dates.  During 
the study period, the plan altered the program requirements 
such that phone-based CMRs were not reimbursable; 
however, patient follow-up via phone after the face-to-face 
encounter was allowed.  Offering home-based or telephone 
visits may increase participation rates.  Alternatively, seeing 
the patient at the clinician’s office prior to the post-discharge 
medical appointment may be feasible. 
 
Goal:  Ensure clear communication between pharmacists, 
patients, and clinicians  
Barrier:  Barriers were encountered related to tracking 
acceptance rates of recommendations, regardless of whether 
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the participant obtained medications at the supermarket 
chain pharmacy or elsewhere.  In particular, maintaining 
pharmacist-patient and pharmacist-clinician communication 
was challenging.  
 
Strategy:  Marketing the service to clinicians may increase 
rates of recommendation approval and follow-up with the 
community pharmacist.  Additional planned telephone calls 
with patients may help to better identify acceptance rates of 
recommendations.  A list of standardized questions with a 
system to document responses may ensure consistently of 
the follow-up service.  Streamlining the data collection and 
recording process may increase efficiency and yield more 
complete results.  
 
Goal:  Distinguish between planned and unplanned 
readmissions 
Barrier:  Several patients alluded to anticipated hospital 
readmissions (e.g. planned childbirth).  While specific rules 
apply to hospitals facing excessive readmissions, there may 
be benefit in identifying the actual rate of planned and 
unplanned hospital readmissions. 
 
Strategy:   Programs with access to the patient’s medical 
records may be able to identify anticipated hospital 
readmissions.  An alternative approach may be to incorporate 
a question during the face-to-face session, such as “Do you 
expect to have to go back to the hospital during the next 30 
days?”  Any affirmative response should be explored further 
to clarify if a planned readmission is scheduled or if the 
participant feels he was prematurely discharged.   
 
Goal:  Identify the amount of time required to provide this 
service 
Barrier: As an insurer, community pharmacy, and internet-
based MTM platform collaborated on this program, it was not 
possible to fully identify how much total time was required 
among the organizations on a per patient basis.  At the 
pharmacy level, it was difficult to track total time because the 
program involved several distinct activities, including 
enrolling patients, conducting face-to-face visits, and 
following up with patients and clinicians.    
 
Strategy:  The face-to-face session was provided during non-
dispensing time.  By breaking other components of the TOC 
program into smaller tasks, study pharmacists were able to 
more efficiently use time available when practicing in a 
dispensing role.  Examples of activities that may be feasible to 
work on when time is available throughout the day include 
calling potential participants, compiling an initial medication 
history, documentation, and billing of the service.  Developing 
a systematic process was instrumental in allowing study 
pharmacists to provide components of the TOC service 
between other responsibilities.  While this created a 
challenge related to identifying time spent per patient, this 
integrated approach may allow the program to be 
implemented in other community pharmacies in which 
pharmacists work in both dispensing and non-dispensing 
roles. 
 
Consideration should be given to incorporation of ancillary 
staff to decrease the time required by pharmacists for non-
clinical components of the service.  Examples of activities that 
trained pharmacy technicians may be able to participate in 
include scheduling patients, collecting information prior to 
the patient visit, documentation, and billing.
27
 
 
Next Steps 
Pharmacists should seek to develop programs that support 
national, state, and local goals.  This may increase 
collaboration opportunities, facilitate reimbursement, and 
improve patient health outcomes.  During the development 
of the TOC service, limited information existed regarding the 
barriers community pharmacists may face when 
implementing a MTM service for patients with managed 
Medicaid.  Focusing on patients as they transitioned from the 
inpatient to outpatient setting added a layer of complexity.  
This pilot project may help provide a foundation for the 
development of other MTM-based TOC services within the 
community pharmacy setting. 
 
Several areas of potential future research have been 
identified.  Larger studies are needed to assess the impact of 
an MTM-based TOC service provided by community 
pharmacists on hospital readmission rates.  Further 
development and assessment of partnerships with 
stakeholders, as well as strategies to best meet the needs of 
patients at high risk for hospital readmission, is warranted.  
Finally, further implementation of the Affordable Care Act is 
anticipated to increase the number of patients eligible for 
Medicaid, and potentially the diversity of the population.  
Ongoing research regarding patient needs is necessary, 
particularly related to areas where disparities exist, such as 
hospital readmission rates.   
 
Conclusion 
Developing and implementing a community pharmacy MTM-
based TOC program for patients with managed Medicaid was 
logistically feasible.  As national attention continues to be 
placed on reducing hospital readmission rates, additional 
research is needed regarding strategies for best incorporating 
community pharmacists in TOC services. 
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Table 1: Demographic and health information of patients enrolled in study 
 
Characteristic (range) Female (n=10) Male (n=7) Total 
Average age in years 41.7 (19-64) 51.7 (41-68) 45.8 
Average years of formal education 10.8 (5-14) 11 (9-12) 10.8 
Average number of medications 10.8 (3-24) 10.3 (2-18) 10.6 
Average number of conditions 6 6.5 6.2 
 
 
 
Table 2: Frequency of pharmacologic and behavior modification recommendations 
 
Number of pharmacologic recommendations # Number of patients receiving behavior 
modification recommendations 
# 
Indication 20 Healthy food choices 9 
Underuse 9 Medication non-adherence 9 
Safety 8 Physical activity 7 
Administration/ technique 6 Smoking cessation 5 
Overuse 5 Diabetes self-management skills 4 
Efficacy 2 Stress reduction 2 
Total 50 Total 36 
 
 
 
Table 3: Frequency of recommendations based on number of medications 
 
Number of medications Number of participants Average number of 
pharmacologic 
recommendations 
Average number of non-
pharmacologic 
recommendations 
5 or fewer 4 0.75 1.25 
6 to 10 5 3.4 2.8 
11 to 15 5 4.2 2.2 
16 or more 3 6.3 3 
 
 
 
 
